Rituximab Combined With Chidamide and Lenalidomide for r/r AITL

Clinical trial NCT04319601 · UNKNOWN

Trial details

NCT number: NCT04319601
Sponsor: Zhejiang Cancer Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Angioimmunoblastic T-cell Lymphoma Chemotherapy Effect Chemotherapeutic Toxicity

Start date: 2020-03-13
Primary completion: 2022-03-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.